The Release of Cytochrome c from Mitochondria during Apoptosis of NGF-Deprived Sympathetic Neurons Is a Reversible Event

During apoptosis induced by various stimuli, cytochrome c is released from mitochondria into the cytosol where it participates in caspase activation. This process has been proposed to be an irreversible consequence of mitochondrial permeability transition pore opening, which leads to mitochondrial s...

Full description

Saved in:
Bibliographic Details
Published inThe Journal of cell biology Vol. 144; no. 5; pp. 883 - 889
Main Authors Martinou, Isabelle, Desagher, Solange, Eskes, Robert, Antonsson, Bruno, André, Elisabeth, Fakan, Stanislav, Martinou, Jean-Claude
Format Journal Article
LanguageEnglish
Published United States Rockefeller University Press 08.03.1999
The Rockefeller University Press
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:During apoptosis induced by various stimuli, cytochrome c is released from mitochondria into the cytosol where it participates in caspase activation. This process has been proposed to be an irreversible consequence of mitochondrial permeability transition pore opening, which leads to mitochondrial swelling and rupture of the outer mitochondrial membrane. Here we present data demonstrating that NGF-deprived sympathetic neurons protected from apoptosis by caspase inhibitors possess mitochondria which, though depleted of cytochrome c and reduced in size, remained structurally intact as viewed by electron microscopy. After reexposure of neurons to NGF, mitochondria recovered their normal size and their cytochrome c content, by a process requiring de novo protein synthesis. Altogether, these data suggest that depletion of cytochrome c from mitochondria is a controlled process compatible with function recovery. The ability of sympathetic neurons to recover fully from trophic factor deprivation provided irreversible caspase inhibitors have been present during the insult period, has therapeutical implications for a number of acute neuropathologies.
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Article-1
ObjectType-Feature-2
Address correspondence to J.-C. Martinou, Serono Pharmaceutical Research Institute, Ares Serono International S.A., 14 chemin des Aulx, CH-1228 Plan-les-Ouates, Geneva, Switzerland. Tel.: (41) 22 706 9822. Fax: (41) 22 794 6965. E-mail: jean-claude.martinou.ch_gva03@serono.com
ISSN:0021-9525
1540-8140
DOI:10.1083/jcb.144.5.883